FindTrial
Sign In

Assessment of Quality of life in Lung Cancer Patients

Longitudinal Assessment of Quality of Life among Stage IV Non Small Cell Lung Cancer Patients in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/09/006215
Enrollment
200
Registered
2015-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Lung cancer Patients

Interventions

Intervention1: Not Applicable: ---- Control Intervention1: Not Applicable: ---

Sponsors

Not yet decided
Lead Sponsor
Not yet decided
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age >= 18 years 2)Patients diagnosed with stage IV NSCLC 3) Patients who consent to participate (via a signed informed consent form) 4) Patients with no previous history of malignant disease

Exclusion criteria

Exclusion criteria: 1.Patients with lung cancers other than NSCLC 2.Patients with stage I-III cancers 3.Patients with active cancer other than NSCLC 4.Patients who had received prior chemotherapy 5.Patient charts that do not include the minimum data set

Design outcomes

Primary

MeasureTime frame
The primary objective of the study is to evaluate longitudinal changes in quality of life among patients receiving palliative systemic therapy for Stage IV NSCLC.Timepoint: At Start of the study, then 2 months and then 5 months—

Secondary

MeasureTime frame
The secondary objective of this study is to examine the relationship of the EORTC QLQ-C30 and LC-13 scales and survival in patients with stage IV NSCLC.Timepoint: After 12 months—

Countries

India

Contacts

Public ContactDr Amit Joshi

Tata memorial Hospital

dramit74@yahoo.com09769331525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026